ResearchMoz

PharmaPoint: Major Depressive Disorder - US Drug Forecast and Market Analysis to 2023

 

Albany, NY -- (ReleaseWire) -- 06/26/2014 -- Summary

Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for top selling products, such as Eli Lillys Cymbalta, and Otsuka/BMSs Abilify, along with the recent launch of the multimodal antidepressant, Lundbeck/Takedas Brintellix, in January 2014, and the potential introduction of seven promising late-stage pipeline products into the market during the forecast period, from 2013 to 2023.

Browse Detail Report With TOC @ http://www.researchmoz.us/pharmapoint-major-depressive-disorder-us-drug-forecast-and-market-analysis-to-2023-report.html

The value of the US market is expected to fall following patent expiries for Eli Lillys Cymbalta in 2013, Otsuka Pharmaceutical/BMSs Abilify in 2015, and AstraZenecas Seroquel XR in 2017. After a period of declining sales, GlobalData estimates that the MDD market in the US will follow a steady growth trend from 2018 to 2023.

Scope

- Overview of Major depressive disorder including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.

- Detailed information on the key drugs in the US including product description, safety and efficacy profiles as well as a SWOT analysis.

- Sales forecast for the top drugs in the US from 2013-2023.

- Analysis of the impact of key events as well the drivers and restraints affecting the US Major depressive disorder market.

For Market Research Latest Reports Visit @ http://www.researchmoz.us/latest-report.html

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return

- Stay ahead of the competition by understanding the changing competitive landscape for Major depressive disorder.

- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential

- Make more informed business decisions from insightful and in-depth analysis of drug performance

- Obtain sales forecast for drugs from 2013-2023 in the US.

About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:
Email: sales@researchmoz.us